China's golden decade of medical devices is coming, and upward growth change has come.

On October 12, 2020 Medical Device Industry Innovation and Development Conference was held in Shaoxing, which was co-sponsored by Shaoxing Municipal Government, Shaoxing Yuecheng Medical Device Industry Innovation Service Complex, Arterial Network, etc.
participated in the conference mainly from the national medical device industry related fields of experts, business representatives, relevant institutions, hospital leaders, the relevant departments in the city.
Shaoxing Medical Device Industry Innovation and Development Conference is not only Shaoxing City for the future urban construction of health care, but also the Cross-City complex for the landing enterprise services and ecological construction efforts.
Since the establishment of Shaoxing Binhai New Area in November last year, the region has made great efforts in scientific and technological innovation, built a high-end biopharmaceutical industry platform and industrial innovation service complex as an opportunity to build a comprehensive base for life and health in the Yangtze River Delta region, build a high-energy innovation platform, and strive to become a biomedical subdivision area, forming a medical device-oriented, focusing on medical new materials, medical imaging equipment, medical high-value consumables diagnostic reagents and other fields to set up a national inspection and testing base.
recently, Shaoxing Binhai New Area approved the establishment of a series of industrial support policies, such as a series of heavy-weight policy release of the super-bonus, for the development and growth of related industries to provide a strong support.
today, the medical device complex innovation flyer Beijing Peking University Medical Device Innovation Center was unveiled, and further promote this process.
against the background of the New Crown epidemic, the state and local governments have also been more active in introducing medical industry science and technology, building a good medical and health industry ecology, Shaoxing as an important link in the future urban construction of medical health care, medical and health innovative industrial cluster construction.
Shaoxing Yuecheng Medical Device Industry Innovation Service Complex is the representative of Shaoxing City Innovation Cluster Construction.
supported by industrial environment and policy dividends, the number of Shaoxing medical device enterprises is also increasing, as of August 2020, more than 400 enterprises have obtained medical device production licenses.
scale of the pharmaceutical industry is also growing rapidly, from January to July 2020, the total output value of enterprises on the medical device regulations in Yuecheng Reached 4,712 million yuan, including Mingfeng Medical, Zhending Medical.
China's medical device market has become the world's second largest market, and the next decade is still China's medical device industry rapid development of the "golden period."
expected the global medical device market to reach $477.5 billion by 2020, with a compound annual growth rate of 4.1% between 2016 and 2020.
Well-known medical device policy experts, China's medical device industry development report Blue Book editor-in-chief Geng Hongwu well-known medical device policy experts, China's medical device industry development report Blue Book editor-in-chief Geng Hongwu pointed out that the next decade will be the fastest growing medical devices.
medical devices may give us more important to human health than medicine.
, citing data from the 2020 Edition of the Blue Book of Medical Devices, he pointed out that China's 18,070 medical device enterprises are extremely unevenly distributed throughout the country, with the top seven provinces accounting for about 63% of the total sales data. 16% growth rate, "2020 edition of the Blue Book of Medical Devices" forecast 2019 is 730 billion overall sales, then by 2020 the entire medical device sector will break trillion, maintain a very good momentum of development.
geng Hongwu also pointed out that China's medical devices have imported medical device products far higher than the difference rate of domestic medical devices characteristics, in the first place is orthopaedics, the second is the department of heart medicine, the third is neurology.
the past five years and 13th Five-Year Plan period, the country has carried out a series of reform measures, the impact on the pharmaceutical sector is huge, the field of medical devices has just begun.
for the medical device sector, 2020 from a policy perspective, hot issues may focus on price reduction, fee control, major procurement, two-vote system, which will have a huge impact on the industry as a whole.
we have seen a change in the pattern of pharmaceutical production since the implementation of zero price differentials across the pharmaceutical industry in 2016.
in compliance control, the second half of this year entered the most stringent era, issued a large number of documents, including the first two days of the introduction of pharmaceutical filings and other related policies.
medical devices account for only a quarter of the industry's output, commercial bribery cases account for more than 50%.
Geng Hongwu team combed through 908 medical device documents and more than 6000 documents and found that centralized bidding and procurement, medical insurance system, flight inspection has become the core focus of current health policy.
policy will have a significant impact on the healthcare industry in the future.
Geng Hongwu gives ten macro judgments on the future medical device field: First, the medical device industry has entered a new cycle of industrial development.
cycle is closely related to the country's overall economic development and the development of the pharmaceutical industry.
, the policy-driven medical device industry has entered a period of innovation.
, the industry gradually upgraded, the concentration of production and circulation will be increasing day by day, to solve the current situation of how small and scattered the overall situation.
Fourth, new technologies, new models, new supply reform clinical needs, fifth, strict supervision, industry to standardize the nine health direction of development, sixth, domestic product substitution accelerated, home equipment accelerated growth.
, Internet plus penetration and rapid upgrading of the industry.
, the integration of pharmaceutical equipment to guide the development of two-wheel drive enterprises, mergers and acquisitions, capital assistance, a new stage of horse-running circle.
, AI, accompanying diagnosis, and early screening of diseases are the way forward.
that the opening of technological innovation in a new era will be a top priority.
innovation includes product innovation, but also our marketing, management, channels, model innovation, because only innovation can truly grasp the future.
the global TOP20 medical device enterprises, CITIC Construction Investment Securities in addition to domestic substitution is also the focus of this conference to discuss the topic.
Citic Capital Securities Research and Development Department of the pharmaceutical industry analyst Wang Yusan said that the global medical device market is currently very concentrated, in Europe and the United States accounted for more than 50% of the overall market, the world's major medical device companies are concentrated in these markets, China only accounted for about 15%, but in recent years, China's innovation and localization policy has promoted the rapid development of the medical device industry, maintain a high growth rate of 20%, the global growth rate is basically 5%-6%, China as a global market is likely to be like the United States.
source: CITIC Jian investment securities from the track selection, domestic and foreign major tracks mainly include in-body diagnosis, cardiovascular, orthopaedic, ophthalmology and so on.
said China's medical device sector will have to be replaced in the future, except for China's own larger market, which accounts for only a half of the global market share.
the future to be stronger and bigger but also to go out, so not only domestic substitution, but also to consider the issue of global substitution.
first is technology, the second is China's own industrial chain advantages, can reduce costs, which in the domestic and foreign markets and foreign enterprises in the competition to become the first opportunity.
sub-areas, most of the domestic imaging equipment is still in the long-term, and high-value supplies and other products also have a lot of products more mature, high degree of technology, high rate of localization.
such as in the field of cardiovascular devices, many of our products were followed, imitated and learned 20 years ago.
but there are already some products we are in the lead.
is a similar situation in orthopaedics.
the overall situation of medical imaging equipment localization, basically may be relatively small equipment, industrial chain is not dependent on imported equipment, small parts and components of small equipment is easier to import replacement.
and large-scale medical equipment such as CT nuclear magnetic technology maturity is still not high, domestic leading medical imaging equipment enterprises in the cost, raw materials, technology is still in the catch-up stage, product continuous improvement to high-end upgrade.
CT nuclear magnetic is also China's future import substitution of a relatively large market space area.
Medical imaging, color super and endoscope domestic do a better field, there may be three to five years of generation difference, CT nuclear magnetic high-end products may have five years or more of generation difference, but the market space is also very broad.
need to point out that the key core technology components are still not overcome, domestic enterprises have actually tried for many years behind the scenes, invested a lot of resources in research and development, but also made some breakthroughs.
is more likely to break through in the future, Jiang Haochuan, president of Mingfeng Medical, said in a speech today, the key components of the national production CT will soon be facing.
Source: Company official website, company announcement, CITICS Securities Research and Development Department of another sub-area is in-body diagnosis, especially in the field of chemical luminescence, is gradually replacing enzyme-linked immunity, the industry growth rate in the last two years is expected to exceed 20%, the market size is expected to be 26 billion in 2018, the domestic enterprise Meirui next year is expected to become the domestic chemical luminescence leader, become in-body diagnostic field, biochemistry, blood cell immunity and other fields of the leader.
In short, under the influence of the government, industry and capital support, China's medical device innovation is on the road to more prosperity, we will usher in a better era of development, the future "golden decade" can be expected.
JACKZHAO Source: MedSci Original Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Originals" are owned by Metz Medicine and are not authorized to be reproduced by any media, website or individual, and are authorized to be reproduced with the words "Source: Met Medical".
all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
at the same time reproduced content does not represent the position of this site.
leave a message here.